AbCellera Biologics Inc. · NASDAQ:ABCL

Booth Andrew exercised options for 50,000 AbCellera Biologics Inc. shares (Form 4)

Traded Nov 13, 2026 · Filed Nov 16, 2026

On Nov 13, 2026, Booth Andrew (Chief Financial Officer) exercised options for 50,000 AbCellera Biologics Inc. shares at US$0.32 for US$16,080, leaving 491,400 shares. Filed Nov 16, 2026 (Form 4).

Options exercised
50,000 shares
Price
US$0.32
Value
US$16,080
Holding after
491,400 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 13, 2026Common SharesOption exercise50,000US$0.32541,400Direct
Nov 13, 2026Common SharesGift50,000491,400Direct

Source

Download original · View original at SEC

Related